CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Fosmidomycin-clindamycindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00217451
NCT00217451Phase 2Completed
CompareCT.gov

Evaluation of Fosmidomycin in Combination With Clindamycin in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Albert Schweitzer Hospital·interventional·Posted Sep 22, 2005·Updated Sep 22, 2005

In Brief

A Phase 2 clinical trial evaluating Fosmidomycin-clindamycin for Malaria. Completed, across 1 site.

Detailed Summary

Some antibiotics are also effective against malaria parasites. Fosmidomycin is an antibiotic that has been shown to be effective against malaria, although it cannot achieve a total cure in all patients. A previous small study has shown that in combination with clindamycin, an commonly used antibiotic, it is highly effective and safe, in asymptomatic carriers of malaria parasites. The current study will evaluate the efficacy and safety of the combination given for three days in children with uncomplicated malaria in Gabon.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesGabon
Collaborators--

Timeline

Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartJun 1, 2002
Study CompletionMar 1, 2003
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Fosmidomycin-clindamycindrug